Randomized, Double-blind, Active-controlled, Multi-center Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)
Phase of Trial: Phase II
Latest Information Update: 05 Aug 2014
At a glance
- Drugs Revaprazan (Primary) ; Esomeprazole
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions; Therapeutic Use
- Sponsors Yuhan
- 09 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 15 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Apr 2013 Status changed from not yet recruiting to recruiting as reported by Clinical Research Information Service (CriS) - Republic of Korea.